- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Obesity; Endocrine; Diabetes Type 2 in South Africa
Total 1251 results
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Canada
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation, Romania, Poland, Czech Republic, Puerto Rico, Hungary
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States, Germany, Mexico, Romania, Serbia, South Africa, Ukraine, Chile, Peru, Puerto Rico, Austria, Hungary, Slovakia, India, Czechia, Latvia, Argentina, United Kingdom
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Dominican Republic, Chile
-
Orexigen Therapeutics, IncCompletedObesity | Diabetes Mellitus, Type 2 | OverweightUnited States
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States
-
SanofiHanmi Pharmaceutical Company LimitedTerminatedType 2 Diabetes MellitusUnited States, Poland, Ukraine, Hungary
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, United States, Argentina, Brazil, Canada
-
Eli Lilly and CompanyRecruitingType 2 DiabetesTaiwan, United States, China, Mexico, Germany, Poland
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes | HyperlipidemiaUnited States
-
Daiichi Sankyo, Inc.Completed
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Canada, Poland, South Africa, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, United Kingdom, Denmark, Netherlands, Norway, South Africa, Finland, France, Spain, Former Serbia and Montenegro, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Slovakia, Canada, South Africa, Puerto Rico, Poland
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusPuerto Rico, United States, Poland, Slovakia
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, India, Peru, Poland, Czech Republic
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada
-
TakedaCompletedDiabetes MellitusUnited States
-
Eli Lilly and CompanyActive, not recruitingType 2 DiabetesUnited States, Japan, China, India, Mexico, Puerto Rico
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Puerto Rico, Mexico
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Mexico, Taiwan, United States, Israel, Russian Federation, Slovakia, Ukraine, Guatemala, Peru, Romania
-
The University of New South WalesNational Health and Medical Research Council, Australia; Novo Nordisk A/S; Sydney...CompletedType 1 Diabetes | Puberty: >Tanner 2 Breast Development or Testis >4mlAustralia
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
Hoffmann-La RocheCompletedCardiovascular Disease, Diabetes Mellitus Type 2Germany, Spain, Korea, Republic of, United States, Colombia, Mexico, Hungary, Canada, Austria, Estonia, Malaysia, Australia, Poland, Thailand, Czech Republic, Latvia, Italy, Romania, Russian Federation, Chile, Lithuania, Sweden, United... and more
-
Tufts Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American... and other collaboratorsCompleted
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Spain, United States, Estonia, Mexico, South Africa, Taiwan, Russian Federation, Canada, Slovakia, United Kingdom, Malaysia, Thailand, Australia, Hungary, Bulgaria, Brazil, Germany, Lithuania, Denmark, Romania, Ukraine, Poland, India, Israe... and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Canada, Mexico, Guatemala, Germany, Brazil, Puerto Rico, Costa Rica
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Puerto Rico
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Canada, United States, Hungary, Poland, Bulgaria, Croatia, Germany, Mexico, Guatemala, Australia
-
GlaxoSmithKlineWithdrawnType 2 Diabetes MellitusUnited States
-
GlaxoSmithKlinePPDCompletedDiabetes Mellitus, Type 2Spain, Germany, Hungary, Italy, Philippines, France, United States, Mexico, Brazil, South Africa, Korea, Republic of, Canada, Poland, United Kingdom
-
Eli Lilly and CompanyActive, not recruitingType 2 DiabetesUnited States, United Kingdom, Germany, Mexico, Romania, Argentina, Canada, Puerto Rico, Israel, Italy, Slovakia
-
University of AdelaideRoyal Adelaide HospitalCompletedInsulin Resistance | Diabetes Mellitus, Type IIAustralia
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, China, Japan, Argentina, Puerto Rico, Mexico
-
SanofiTerminated
-
Eli Lilly and CompanyInsulet CorporationCompletedType 2 Diabetes MellitusUnited States, Puerto Rico
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusCanada, United States, Italy, Poland, Puerto Rico
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States
-
Barnsley HospitalCompletedType 2 Diabetes | Peripheral Vascular Disease | HypogonadismUnited Kingdom
-
Eli Lilly and CompanyCompletedDiabetes | Type 2 DiabetesUnited States, China, Germany, Mexico, Brazil, Canada, Japan, Korea, Republic of, Puerto Rico, Czechia, Greece
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Austria, Canada, Italy, Netherlands, Spain, United Kingdom, Taiwan, Thailand, Bulgaria, Belgium, Germany, Korea, Republic of, Hungary, Philippines, China, Malaysia, Hong Kong, New Zealand, Argentina, Czechia, Slovakia, Braz... and more